|
2013
|
Invention
|
Pneumococcal vaccine and uses thereof. The present invention relates to new pneumococcal vaccines... |
|
|
Invention
|
Immunostimulatory oligonucleotides. The invention relates to immunostimulatory oligonucleotides a... |
|
2012
|
Invention
|
Combination motif immune stimulatory oligonucleotides with improved activity.
Immunostimulatory ... |
|
2011
|
Invention
|
Anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cance... |
|
|
Invention
|
Vaccines comprising cholesterol and cpg as sole adjuvant - carrier molecules. Described are vacci... |
|
|
Invention
|
Immunostimulatory dna:rna oligonucleotides.
Immunostimulatory sequence-specific RNA oligonucleot... |
|
2010
|
Invention
|
Methods and products related to treatment and prevention of hepatitis c virus infection.
The inv... |
|
|
Invention
|
Methods related to immunostimulatory nucleic acid-induced interferon.
Methods and compositions a... |
|
|
Invention
|
Pneumococcal vaccine and uses thereof.
The present invention relates to new pneumococcal vaccine... |
|
2009
|
Invention
|
Immunostimulatory oligoribonucleotides.
The invention provides immunostimulatory compositions an... |
|
|
Invention
|
Nucleic acid-lipophilic conjugates.
The invention relates to a nucleic acid-lipophilic conjugate... |
|
|
Invention
|
Nucleic acid compositions for stimulating immune responses. The invention provides an immunostimu... |
|
2008
|
Invention
|
Semi-soft c-class immunostimulatory oligonucleotides. The invention relates to specific C-Class s... |
|
|
Invention
|
Triazole compounds as toll-like receptor (tlr) agonists. Certain triazole compounds are disclosed... |
|
|
Invention
|
Pyrimidine compounds as toll-like receptor (tlr) agonists. Certain pyrimidine compounds are discl... |
|
|
Invention
|
Immunostimulatory nucleic acid oil-in-water formulations and related methods of use.
The inventi... |
|
|
Invention
|
Combination motif immune stimulatory oligonucleotides with improved activity. Immunostimulatory o... |
|
|
Invention
|
Combination motif immune stimulatory oligonucleotides with improved activity. lmmunostimulatory o... |
|
|
Invention
|
Quinazoline derivative useful as toll-like receptor antagonist. Compound CPG 52364 having formula... |
|
|
Invention
|
Sulfonamido ether substituted imidazoquinolines.
Imidazoquinoline and tetrahydroimidazoquinoline... |
|
|
Invention
|
Class a oligonucleotides with immunostimulatory potency. The invention provides an immunostimulat... |
|
|
Invention
|
Process for imidazo [4,5-c] pyridin-4-amines.
A process and intermediates for preparing 1H-imida... |
|
|
Invention
|
Methods and compositions for inducing innate immune responses.
The invention relates to TLR liga... |
|
2007
|
Invention
|
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp).
Impr... |
|
|
Invention
|
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp). Impro... |
|
|
Invention
|
Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use. S... |
|
|
Invention
|
Compositions of tlr ligands and antivirals.
The invention relates to methods and products for th... |
|
|
Invention
|
Compositions of tlr ligands and antivirals. The invention relates to methods and products for the... |
|
|
Invention
|
Fungicidal methods using immune response modifier compounds. The present invention provides metho... |
|
|
Invention
|
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides. The invention ... |
|
|
Invention
|
Small molecule inhibitors of toll-like receptor 9. Small molecule compounds and compositions cont... |
|
|
Invention
|
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods. Substituted fused [l,2... |
|
|
Invention
|
Substituted tetrahydroimidazonaphthyridines and methods. 6,7,8,9-Tetrahydro-1H-imidazo[4,5-c]naph... |
|
|
Invention
|
Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods. 1H-Imidazo[4,5-c]naphthyridi... |
|
|
Invention
|
Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods. [1,2]Imidazo[4,5-c] ring compoun... |
|
|
Invention
|
Compositions and methods for oligonucleotide formulations. The present invention relates generall... |
|
2006
|
Invention
|
Immunomodulatory oligonucleotides.
Oligonucleotides containing unthylated CpG dinucleotides and ... |
|
|
Invention
|
Immunostimulatory nucleic acid molecules. Nucleic acids containing unmethylated CpG dinucleotides... |
|
|
Invention
|
Detoxified endotoxin vaccine and adjuvant and uses thereof.
The present invention describes a de... |
|
|
Invention
|
Small molecule toll-like receptor (tlr) antagonists.
The invention provides methods and composit... |
|
|
Invention
|
Immunostimulatory nucleic acids. The invention relates to a class of soft or semi-soft CpG immuno... |
|
|
Invention
|
Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy ... |
|
|
Invention
|
Immunostimulatory oligonucleotides.
The invention relates to a class of short CpG immunostimulat... |
|
|
Invention
|
Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods. Thiazolo[4,5-c] r... |
|
2005
|
Invention
|
Immunomodulatory compositions, combinations and methods.
The invention provides immunomodulatory... |
|
|
Invention
|
1-amino imidazo-containing compounds and methods.
Imidazo-containing compounds (e.g., imidazonap... |
|
|
Invention
|
Substituted imidazo ring systems and methods.
Imidazo ring systems, which include, for example, ... |
